Nipocalimab | Interleukin Related interleukin-related.com

Product Name :
Nipocalimab

Search keywords :
Nipocalimab

drugId :
null

Target Vo:
IgG receptor FcRn large subunit p51

Target Vo Short Name :
FCGRT

Moa_Name:
IgG receptor FcRn large subunit p51 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Momenta

Active Company_Name :
Catalent Cts Llc

Active Indication_Name:
Thrombocytopenia, Neonatal Alloimmune

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse Ly-6G/Ly-6C Antibody (RB6-8C5) Epigenetic Reader Domain
eIF4E Rabbit mAb Autophagy
beta III Tubulin Antibody: beta III Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta III Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts